William Looney: In terms of nation-state actors, can we identify where the pressure points on cybersecurity are coming from?
Mollie Shields-Uehling, SAFE-BioPharma: In biopharma, this is relatively easy to determine. Each year, the R&D industry’s trade organization, PhRMA, submits...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?